Zacks Research Raises Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Zacks Research increased their FY2024 earnings per share (EPS) estimates for Henry Schein in a research report issued on Tuesday, November 26th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $4.76 for the year, up from their prior forecast of $4.73. The consensus estimate for Henry Schein’s current full-year earnings is $4.78 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.21 EPS, Q1 2025 earnings at $1.17 EPS, Q2 2025 earnings at $1.28 EPS, Q3 2025 earnings at $1.31 EPS, Q4 2025 earnings at $1.40 EPS, FY2025 earnings at $5.15 EPS, Q1 2026 earnings at $1.35 EPS, Q2 2026 earnings at $1.39 EPS and FY2026 earnings at $5.61 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 earnings per share.

A number of other analysts have also weighed in on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Robert W. Baird dropped their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. Evercore ISI lifted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and an average target price of $79.38.

Henry Schein Price Performance

HSIC opened at $77.66 on Thursday. The company has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.96, a PEG ratio of 2.20 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63. The business’s fifty day simple moving average is $71.15 and its 200-day simple moving average is $69.78.

Hedge Funds Weigh In On Henry Schein

A number of large investors have recently bought and sold shares of the business. California State Teachers Retirement System lifted its position in shares of Henry Schein by 1.7% during the 1st quarter. California State Teachers Retirement System now owns 212,108 shares of the company’s stock valued at $16,018,000 after buying an additional 3,534 shares in the last quarter. Tidal Investments LLC raised its stake in Henry Schein by 21.4% in the 1st quarter. Tidal Investments LLC now owns 5,632 shares of the company’s stock valued at $425,000 after purchasing an additional 994 shares during the last quarter. Wahed Invest LLC raised its stake in Henry Schein by 14.3% in the 1st quarter. Wahed Invest LLC now owns 2,540 shares of the company’s stock valued at $192,000 after purchasing an additional 318 shares during the last quarter. DNB Asset Management AS lifted its holdings in Henry Schein by 18.5% in the 2nd quarter. DNB Asset Management AS now owns 26,731 shares of the company’s stock valued at $1,713,000 after purchasing an additional 4,176 shares in the last quarter. Finally, Beach Investment Counsel Inc. PA acquired a new stake in Henry Schein during the 2nd quarter worth $37,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Buying and Selling

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.